• LAST PRICE
    5.9900
  • TODAY'S CHANGE (%)
    Trending Up0.1000 (1.6978%)
  • Bid / Lots
    5.9300/ 16
  • Ask / Lots
    6.0900/ 1
  • Open / Previous Close
    5.9400 / 5.8900
  • Day Range
    Low 5.8400
    High 5.9900
  • 52 Week Range
    Low 4.6650
    High 6.5291
  • Volume
    37,761
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 5.89
TimeVolumeKMDA
09:32 ET31095.94
09:33 ET6045.94
09:35 ET9655.94
09:37 ET8365.95
09:39 ET5005.95
09:42 ET1005.94
09:44 ET29005.95
09:46 ET3005.95
09:48 ET24355.9499
09:50 ET21925.9499
09:51 ET10415.95
09:53 ET36045.9499
10:00 ET12505.94
10:02 ET15225.94
10:06 ET1865.94
10:08 ET1005.93
10:18 ET1005.93
10:29 ET20105.9
10:38 ET1005.9
10:40 ET1805.9
11:38 ET10005.8505
11:50 ET1005.86
12:03 ET2005.87
12:10 ET1005.87
12:17 ET1005.86
12:24 ET3005.86
12:26 ET2005.85
12:50 ET1005.86
01:00 ET1025.85
01:31 ET2005.84
01:38 ET3005.87
01:44 ET1005.875
02:09 ET1005.86
02:18 ET1315.85
02:23 ET1005.86
02:27 ET1005.85
02:34 ET9425.9
02:50 ET1005.935
02:59 ET1005.92
03:08 ET1005.9
03:30 ET1375.9236
03:33 ET1005.935
03:37 ET3115.9301
03:51 ET1005.95
03:53 ET6605.9899
03:55 ET3005.955
03:57 ET1005.98
04:00 ET7345.99
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKMDA
Kamada Ltd
334.0M
19.3x
-22.48%
United StatesSTRO
Sutro Biopharma Inc
221.8M
-1.7x
---
United StatesKPTI
Karyopharm Therapeutics Inc
109.8M
-1.0x
---
United StatesHRTX
Heron Therapeutics Inc
176.4M
-6.6x
---
United StatesMCRB
Seres Therapeutics Inc
149.7M
-0.8x
---
United StatesARCT
Arcturus Therapeutics Holdings Inc
474.3M
-8.0x
---
As of 2024-12-03

Company Information

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Contact Information

Headquarters
2 Holtzman St., Science ParkREHOVOT, Israel 7670402
Phone
---
Fax
---

Executives

Chairman of the Board
Lilach Asher Topilsky
Chief Executive Officer
Amir London
Deputy Chairman of the Board
David Tsur
Chief Financial Officer
Chaime Orlev
Senior Vice President - Scientific Affairs
Ruth Wolfson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$334.0M
Revenue (TTM)
$158.4M
Shares Outstanding
57.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.99
EPS
$0.31
Book Value
$4.25
P/E Ratio
19.3x
Price/Sales (TTM)
2.1
Price/Cash Flow (TTM)
11.7x
Operating Margin
11.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.